UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3140) 3140
Newsletter (175) 175
Newspaper Article (129) 129
Magazine Article (16) 16
Dissertation (11) 11
Book Chapter (9) 9
Publication (6) 6
Conference Proceeding (5) 5
Transcript (3) 3
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pemetrexed (3116) 3116
humans (2046) 2046
science & technology (1942) 1942
life sciences & biomedicine (1898) 1898
oncology (1541) 1541
guanine - analogs & derivatives (1376) 1376
female (1145) 1145
lung neoplasms - drug therapy (1131) 1131
male (1103) 1103
chemotherapy (1017) 1017
middle aged (981) 981
aged (953) 953
cancer (891) 891
carcinoma, non-small-cell lung - drug therapy (891) 891
antineoplastic combined chemotherapy protocols - therapeutic use (885) 885
glutamates - administration & dosage (750) 750
guanine - administration & dosage (750) 750
lung cancer, non-small cell (683) 683
adult (655) 655
lung cancer (653) 653
lung neoplasms - pathology (631) 631
treatment outcome (581) 581
care and treatment (571) 571
glutamates - therapeutic use (516) 516
guanine - therapeutic use (516) 516
research (504) 504
carcinoma, non-small-cell lung - pathology (435) 435
cisplatin - administration & dosage (432) 432
antineoplastic agents - therapeutic use (419) 419
neoplasm staging (382) 382
carboplatin (379) 379
respiratory system (370) 370
non-small cell lung cancer (365) 365
aged, 80 and over (356) 356
mesothelioma (352) 352
cancer therapies (342) 342
glutamates - adverse effects (341) 341
guanine - adverse effects (341) 341
mesothelioma - drug therapy (322) 322
prognosis (321) 321
metastasis (318) 318
cisplatin (299) 299
pharmacology & pharmacy (298) 298
disease-free survival (292) 292
antineoplastic combined chemotherapy protocols - adverse effects (290) 290
pemetrexed - administration & dosage (288) 288
lung neoplasms - mortality (284) 284
drug therapy (280) 280
deoxycytidine - analogs & derivatives (273) 273
hematology, oncology and palliative medicine (260) 260
oncology, experimental (243) 243
analysis (241) 241
carcinoma, non-small-cell lung - mortality (241) 241
antineoplastic agents (240) 240
lung cancer, small cell (240) 240
carboplatin - administration & dosage (239) 239
survival rate (239) 239
adenocarcinoma - drug therapy (235) 235
retrospective studies (232) 232
glutamates - pharmacology (228) 228
guanine - pharmacology (228) 228
antimitotic agents (226) 226
patients (223) 223
lung neoplasms - genetics (222) 222
health aspects (221) 221
tumors (215) 215
pleural neoplasms - drug therapy (211) 211
clinical trials (210) 210
mutation (208) 208
cell line, tumor (205) 205
bevacizumab (204) 204
deoxycytidine - administration & dosage (204) 204
animals (202) 202
antimetabolites, antineoplastic - therapeutic use (197) 197
pulmonary/respiratory (189) 189
survival analysis (185) 185
pemetrexed - therapeutic use (176) 176
physical fitness (174) 174
medicine & public health (173) 173
nsclc (166) 166
carcinoma, non-small-cell lung - genetics (164) 164
antineoplastic agents - adverse effects (163) 163
genetic aspects (162) 162
mesothelioma - pathology (161) 161
immunotherapy (158) 158
neoplasms. tumors. oncology. including cancer and carcinogens (158) 158
follow-up studies (156) 156
antineoplastic combined chemotherapy protocols - administration & dosage (151) 151
development and progression (149) 149
gemcitabine (149) 149
antineoplastic agents - administration & dosage (144) 144
antineoplastic agents - pharmacology (144) 144
drug administration schedule (142) 142
adenocarcinoma - pathology (136) 136
non-small cell lung carcinoma (135) 135
thymidylate synthase - antagonists & inhibitors (133) 133
erlotinib (130) 130
medical research (130) 130
pulmonary and respiratory medicine (130) 130
adenocarcinoma (128) 128
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3282) 3282
French (75) 75
Japanese (72) 72
Chinese (53) 53
Spanish (16) 16
German (14) 14
Korean (11) 11
Italian (8) 8
Portuguese (8) 8
Czech (5) 5
Polish (5) 5
Russian (5) 5
Hungarian (3) 3
Danish (1) 1
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of thoracic oncology, ISSN 1556-0864, 01/2019, Volume 14, Issue 1, pp. 124 - 129
Journal Article
The New England journal of medicine, ISSN 1533-4406, 02/2017, Volume 376, Issue 7, pp. 629 - 640
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 09/2016, Volume 34, Issue 25, pp. 2969 - 2979
Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2014, Volume 371, Issue 23, pp. 2167 - 2177
The ALK inhibitor crizotinib as first-line therapy was associated with a significantly better response rate, longer progression-free survival, and greater... 
Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Cisplatin - administration & dosage | Pyridines - adverse effects | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Pyrazoles - adverse effects | Pyridines - therapeutic use | Kaplan-Meier Estimate | Carboplatin - administration & dosage | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Pemetrexed | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Glutamates - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Adenocarcinoma - mortality | Guanine - administration & dosage | Crizotinib | Treatment outcome | Chemotherapy | Usage | Care and treatment | Lung cancer | Analysis | Dosage and administration | Comparative analysis | Risk factors | Cancer | Appetite | Edema | Inhibitor drugs | Intravenous administration | Biomedical research | Diarrhea | Non-small cell lung carcinoma | Fatigue | Nausea | Metastasis | Patients | Cisplatin | Quality of life | Lungs | Platinum | Vomiting | Comparative studies | Carboplatin | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article